Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting Non-phase study NCT07735494

Physical Activity Promotion and Clinical Remission in Severe Asthma

Physical Activity Promotion and Clinical Remission in Severe Asthma — Recruiting • Non-phase study • Respiratory / COPD / Asthma • NCT07735494.

📅 30 Jul 2026 ⏱ 2 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
Phase
Non-phase study
NCT ID
NCT07735494
Sponsor
University of Leeds
Start
2026-07
ClinicaliQ Trial Snapshot
  • Physical Activity Promotion and Clinical Remission in Severe Asthma — Recruiting • Non-phase study • Respiratory / COPD / Asthma • NCT07735494.
  • What is being tested: A structured physical activity promotion programme combined with tezepelumab (a biologic therapy) versus standard care alone, to determine if exercise intervention enhances clinical remission rates in adults with severe asthma.
  • Patient eligibility overview: Adults with severe asthma who are candidates for tezepelumab treatment; this targets patients with difficult-to-control disease despite optimised conventional therapy and other biologic options.
Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

This study will investigate whether a structured physical activity promotion programme, delivered alongside standard treatment with tezepelumab, increases the proportion of adults with severe asthma achieving clinical remission compared with standard care alone. Although biologic therapies have improved asthma control for many people with severe asthma, many individuals remain physically inactive, experience reduced exercise tolerance, and continue to report symptoms that affect their quality of life. Physical inactivity may represent a modifiable factor that limits the achievement of optimal health outcomes. Adults with severe asthma who are starting tezepelumab as…

Eligibility Snapshot
  • : * Adults aged 18-70 years. * Physician-diagnosed severe asthma. * Eligible for tezepelumab according to NICE TA880. * History of ≥3 asthma exacerbations requiring oral corticosteroids in the previous 12 months or receiving maintenance oral corticosteroid therapy. * Objective confirmation of asthma, including bronchodilator reversibility, bronchial hyperresponsiveness and/or variable airflow obstruction, as part of routine clinical assessment. * Decision to commence tezepelumab made by the treating multidisciplinary severe asthma team prior to study enrolment. * Able and willing to provide written informed consent.

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
Ending corridor care in hospitals for children a priority, says health secretary
Respiratory / COPD / Asthma · BBC Health · 18 Oct 2026
Health Secretary Yvette Cooper has prioritised eliminating corridor care for paediatric patients in NHS hospitals, addressing a significant gap in child patient…
View brief →
Clinical Brief
There’s a reason child vaccination rates are falling – and it’s not social media
Respiratory / COPD / Asthma · BBC Health · 03 Aug 2026
Vaccination rates declining across UK: Child immunisation coverage is falling below safe thresholds needed for herd immunity, creating vulnerability to vaccine-preventable disease…
View brief →
Clinical Brief
Mum told to ‘prepare for worst’ urges others to get respiratory illness vaccine
Respiratory / COPD / Asthma · BBC Health · 13 Oct 2026
RSV vaccination in pregnancy is now available and recommended; Jo Goldsmith's case highlights the clinical value of preventing severe respiratory syncytial virus…
View brief →
Clinical Brief
Children keep dying in a country that made huge progress on measles
Respiratory / COPD / Asthma · BBC Health · 08 Jul 2026
Measles Outbreak in Bangladesh: Key Clinical Points Bangladesh is experiencing a major measles outbreak with >120,000 suspected and confirmed cases, indicating potential…
View brief →
Guideline
XVIVO Perfusion System (ex-situ machine perfusion) for assessing and reconditioning marginal lungs for transplantation: early-use assessment
Respiratory / COPD / Asthma · 21 Oct 2026
XVIVO Perfusion System enables ex-situ assessment of marginal donor lungs before transplantation, allowing objective evaluation of organ viability and function to improve…
View guideline →
Clinical Brief
Over one million children referred for mental healthcare – with anxiety the main reason
Respiratory / COPD / Asthma · BBC Health · 29 Jun 2026
Over one million children in England have been referred for mental healthcare, with anxiety as the leading presenting complaint, indicating a substantial…
View brief →